Showing results (31-40 of 3,356) with videos related to
Sort By:
Pageof 336
Psychological Medicine|August 13, 2008
Midlife Neuroticism and the age of onset of Alzheimer's diseaseN Archer, R G Brown, S Reeves, et al.Human Molecular Genetics|August 13, 1998
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's diseaseC Holmes, M J Arranz, J F Powell, et al.Biochemical Society Transactions|January 19, 2006
Overexpression of tau results in defective synaptic transmission in Drosophila neuromuscular junctionsF Chee, A Mudher, T A Newman, et al.Neurology|February 11, 2000
The association between APOE and dementia does not seem to be mediated by vascular factorsM Prince, S Lovestone, J Cervilla, et al.Biochemical Society Symposium|July 13, 2001
Apolipoprotein E gene and Alzheimer's disease: is tau the link?S Lovestone, B Anderton, J Betts, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2001
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variationC Holmes, H Smith, R Ganderton, et al.Acta Neuropathologica|December 14, 1999
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortexD Cotter, M Honavar, S Lovestone, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinctC Strong, B H Anderton, R H Perry, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neuronsO V Forlenza, J M Spink, R Dayanandan, et al.Biological Psychiatry|March 11, 1999
CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modificationJ A Cervilla, C Russ, C Holmes, et al.Pageof 336